Search
eslicarbazepine acetate (Aptiom)
Indications:
- adjunct agent for treatment of partial seizures, epilepsy
- bipolar disorder
- trigeminal neuralgia
Pharmacokinetics:
- prodrug is activated to eslicarbazepine, an active metabolite of oxcarbazepine
Adverse effects:
- dizziness, drowsiness, nausea/vomiting, headache, diplopia, fatigue, ataxia
- suicidal ideation
Mechanism of action:
- sodium channel blocker similar to carbamazepine [3]
- diminishes release of excitatory neurotransmitters
- decreases synaptic transmission
Interactions
drug adverse effects of anticonvulsants
monitor with anticonvulsants
General
anticonvulsant
Database Correlations
PUBCHEM cid=179344
References
- FDA News Release: Nov. 8, 2013
FDA approves Aptiom to treat seizures in adults
http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm374358.htm
- Wikipedia: Eslicarbazepine acetate
http://en.wikipedia.org/wiki/Eslicarbazepine_acetate
- Prescriber's Letter 21(8): 2014
No Detail Document.
(subscription needed) http://www.prescribersletter.com